Funding for this research was provided by:
National Institute of General Medical Sciences (R01GM130777-01)
National Heart, Lung, and Blood Institute (HL007627-33)
Brigham and Women's Hospital (Precision Medicine)
Article History
Received: 21 November 2018
Accepted: 9 August 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: GKG is a Strategic Advisory Board Member of Kaleido Biosciences and had a sponsored research agreement with the company, and is a Scientific Advisory Board Member, co-founder, and shareholder of ConsortiaTX. No funding for the present work was provided by either company. EB is an employee and shareholder of Kintai Therapeutics, which provided no funding for the present work. RC declares that he has no competing interests.